 |
First Blood Test Developed to Reliably Detect Early Colorectal Cancer and Adenomas [ 25/Jan/10 ] |
|
 |
Novel Test Detects Early Pancreatic Cancer [ 25/Jan/10 ] |
|
 |
Higher Omega-3 Fatty Acid Levels Protect Against Cellular Aging in Patients with Coronary Heart Disease [ 22/Jan/10 ] |
|
 |
Expanded Umbilical-Cord Blood Transplants Used Successfully for the First Time in the Treatment of Leukemia [ 21/Jan/10 ] |
|
 |
Added benefit of abatacept in methotrexate-treated early rheumatoid arthritis patients with poor prognosis [ 15/Dec/09 ] |
|
 |
Final Z-FAST Results: Zoledronic Acid Protects Against Bone Loss [ 12/Dec/09 ] |
|
 |
MRI Surveillance in Women with BRCA Mutations [ 10/Dec/09 ] |
|
 |
Novel Immunotherapy Prevents Graft-versus-Host-Disease Associated With Stem Cell Transplants [ 06/Dec/09 ] |
|
 |
Aspirin Alone or in Combination with Heparin Ineffective in Preventing Unexplained Recurrent Miscarriages [ 06/Dec/09 ] |
|
 |
Sequential treatment with erlotinib and chemotherapy significantly improves progression-free survival in patients with non small cell lung cancer [ 20/Oct/09 ] |
|
 |
Targeted Heat Therapy Improves Survival in Soft Tissue Sarcoma Patients [ 24/Sep/09 ] |
|
 |
TAK-1 Inhibition Reverses Chemotherapy Resistance in Pancreatic Cancer [ 24/Sep/09 ] |
|
 |
Nab-paclitaxel demonstrates superior progression free survival compared to docetaxel for metastatic breast cancer patients [ 26/Aug/09 ] |
|
 |
Sunitinib confers survival benefit over Interferon Alfa for Metastatic Renal Cell Carcinoma [ 01/Aug/09 ] |
|
 |
Significant clinical benefit of sorafenib and prognostic value of VEGF in patients with Renal Cell Carcinoma (RCC) [ 29/Jul/09 ] |
|
 |
Influenza vaccine safe and effective for HIV-infected adults in Africa [ 27/Jul/09 ] |
|
 |
Novel point-of-care CD4 T cell count tests unveiled at IAS2009 [ 27/Jul/09 ] |
|
 |
Papilloma virus vaccine effective against cervical precancerous lesions [ 25/Jul/09 ] |
|
 |
New studies dispute cardiovascular risk of abacavir [ 23/Jul/09 ] |
|
 |
Race-specific alleles may account for differing responses to paclitaxel plus carboplatin in Japanese and US non-small cell lung carcinoma patients [ 20/Jul/09 ] |
|